Skip to main content
SpringerLink
Log in
Book cover
  • Book
  • © 1992

Innovations in Antiviral Development and the Detection of Virus Infections

Editors:

  1. Timothy M. Block

    1. Thomas Jefferson University Hospital, Philadelphia, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Donald Jungkind

    1. Thomas Jefferson University Hospital, Philadelphia, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Richard L. Crowell

    1. Hahnemann University School of Medicine, Philadelphia, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  4. Mark Denison

    1. Vanderbilt University, Nashville, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  5. Lori R. Walsh

    1. Mercy Catholic Medical Center, Darby, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 312)

Sections

Buy it now

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (21 chapters)

  1. Front Matter

    Pages i-xvii
    PDF

  3. Drugs as Molecular Tools

    • Frank J. Dutko, Donald E. Baright, Guy D. Diana, M. Pat Fox, Daniel C. Pevear, Mark A. McKinlay
    Pages 15-24

  4. Genetically Engineered Bacteria to Identify and Produce Anti-Viral Agents

    • Robert H. Grafstrom, Katherine Zachariasewycz, Richard A. Brigandi, Timothy M. Block
    Pages 25-40

  7. Therapeutic Strategies Employing CD4, the HIV Receptor

    • Per Ashorn, Bernard Moss, Edward A. Berger
    Pages 71-81

  8. Molecular Characterization of HIV-2 (ROD) Protease Following PCR Cloning from Virus Infected H9 Cells

    • Y.-S. Edmond Cheng, Catherine E. Patterson, Ronald G. Rucker, Michael J. Otto, Christopher J. Rizzo, Bruce D. Korant
    Pages 83-88

  9. A Novel, Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase (Review)

    • Vincent J. Merluzzi, Alan S. Rosenthal
    Pages 89-94

  11. Therapies for Hepatitis B Virus: Current Status and Future Possibilities

    • Paul Martin, Lawrence S. Friedman
    Pages 111-120

  12. A Preliminary Report of a Controlled Study of Thymosin Alpha-1 in the Woodchuck Model of Hepadnavirus Infection

    • John L. Gerin, Brent E. Korba, Paul J. Cote, Bud C. Tennant
    Pages 121-123

  15. Antiviral Effects of Herpes Simplex Virus Specific Anti-Sense Nucleic Acids

    • Edouard M. Cantin, Gregory Podsakoff, Dru E. Willey, Harry Openshaw
    Pages 139-149

  16. Heterogeneity of a Herpes Simplex Virus Clinical Isolate Exhibiting Resistance to Acyclovir and Foscarnet

    • Emanuela Pelosi, Karen A. Hicks, Stephen L. Sacks, Donald M. Coen
    Pages 151-158

  17. Cellular Metabolism and Enzymatic Phosphorylation of 9- (2-Phosphonylmethoxyethyl) Guanine (PMEG),a Potent Antiviral Agent

    • Hsu-Tso Ho, Kathleen L. Woods, Sherry A. Konrad, Hilde De Boeck, Michael J. M. Hitchcock
    Pages 159-166

  19. Procedure for Evaluation of Neutralizing Antibody to Cytomegalovirus in Commercial Intravenous Gamma Globulin Preparations

    • Cindy Wordell, Lorena Chambers, Maryann Durante, Sue DiRenzo, Leigh Hopkins, Donald Jungkind
    Pages 173-182

  20. Improved Detection of Antibodies to Hepatitis C Virus Using a Second Generation Elisa

    • Stephen Lee, John McHutchinson, Brian Francis, Robert DiNello, Alan Polito, Stella Quan et al.
    Pages 183-189
Back to top

About this book

THE ERA OF ANTIVIRALS Introduction Although there are more than one hundred medically useful antibiotics and fungicides, there are only seven compounds licensed for use as antiviral agents, in the USA. Some of these (acyclovir and ganciclovir) are actually derivatives of each other, making the number of new discoveries even smaller. Moreover, most of these agents are of only limited therapeutic value and have substantial toxicity. It has been more than 100 years ago since Pasteur studied rabies virus (2) and Rous (4) showed that a small filterable agent (not bacteria) caused disease (sarcoma) in chickens. It was nearly 100 years ago that yellow fever virus, the first recognized human pathogenic virus, was unambiguously associated with disease (3). Enteroviruses were cultured for the first time nearly 50 years ago (1). Why then has effective chemotherapy against viruses lagged behind that of other microorganisms? Viruses are often difficult to grow and image. However, with the dynamic advances in molecular biology and increased sophistication in tissue culture, the field of virology has blossomed and resulted in improved methods for detection of virus infection. The use of viruses as models of gene regulation and replication has also resulted in a massive accumulation of information.
Back to top

Keywords

Back to top

Editors and Affiliations

  • Thomas Jefferson University Hospital, Philadelphia, USA

    Timothy M. Block, Donald Jungkind

  • Hahnemann University School of Medicine, Philadelphia, USA

    Richard L. Crowell

  • Vanderbilt University, Nashville, USA

    Mark Denison

  • Mercy Catholic Medical Center, Darby, USA

    Lori R. Walsh

Back to top

Bibliographic Information

  • Book Title: Innovations in Antiviral Development and the Detection of Virus Infections

  • Editors: Timothy M. Block, Donald Jungkind, Richard L. Crowell, Mark Denison, Lori R. Walsh

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-1-4615-3462-4

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 1992

  • Hardcover ISBN: 978-0-306-44209-4Published: 30 June 1992

  • Softcover ISBN: 978-1-4613-6533-4Published: 28 October 2012

  • eBook ISBN: 978-1-4615-3462-4Published: 06 December 2012

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XVII, 218

  • Topics: Infectious Diseases, Medical Microbiology, Plant Sciences, Animal Anatomy / Morphology / Histology, Microbial Ecology

Back to top

Publish with us

Policies and ethics

Back to top
Access via your institution

Buy it now

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Search

Navigation